Pharma Reviews: Brexit leaves tech in a jam, but pharma's not too bad

"Brexit led currency volatility should have limited impact on Indian pharma companies," said Anmol Ganjoo, Pharma analyst at JM Financial.
Read more: Brexit leaves tech in a jam, but pharma's not too bad